Document Detail


Relation of prostanoids to strength of hypoxic vasoconstriction in dogs with lobar atelectasis.
MedLine Citation:
PMID:  3839788     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In dogs with acute lobar atelectasis, meclofenamate administration decreases shunt fraction uniformly and moderately without abolishing the wide variation of strength of hypoxic vasoconstriction and resultant variability of shunt fraction (J. Appl. Physiol. 54: 284-289, 1983). To further assess the role of prostanoids, we measured prostanoid metabolites as well as shunt fraction and pressor response to alveolar hypoxia. In six intact anesthetized dogs with acute left lower lobe atelectasis, shunt fraction during normoxia was measured with SF6. Levels of 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha) and thromboxane B2 in arterial, mixed venous, and left lower lobe venous blood were measured with the double antibody radioimmunoassay technique. Ten percent O2 was administered to assess pressor response. Twenty-one percent O2 was restarted, meclofenamate was administered, and measurements were repeated 30 min later. Atelectasis did not elevate levels of prostanoid metabolites. 6-Keto-PGF1 alpha averaged 88 +/- 65 pg/ml prior to atelectasis and 81 +/- 73 pg/ml after atelectasis (F = 0.7, P = NS). Likewise, thromboxane B2 values were normal. No transpulmonary concentration differences were found. 6-Keto-PGF1 alpha did not correlate with shunt values, which ranged from 14 to 35% (mean 21%). Meclofenamate effectively blocked cyclooxygenase, as demonstrated by decreases in prostanoid metabolite levels. It seems likely that in dogs with acute atelectasis prostacyclin localized in the pulmonary vasculature decreases strength of hypoxic vasoconstriction modestly and uniformly without raising blood levels of prostacyclin metabolite.
Authors:
R C Garrett; H M Thomas
Related Documents :
8138278 - Early experience in the surgical treatment of the univentricular heart.
17664208 - Single-stage versus two-stage modified fontan procedure.
18954638 - Design and rationale of a randomized trial comparing the blalock-taussig and right vent...
3789868 - Growth of the pulmonary arteries following blalock-taussig shunt.
19171388 - Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension ...
19540138 - Jugular venous neurone specific enolase (nse) increases following carotid endarterectom...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  59     ISSN:  8750-7587     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  1985 Jul 
Date Detail:
Created Date:  1985-10-03     Completed Date:  1985-10-03     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol (1985)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  72-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
6-Ketoprostaglandin F1 alpha / blood
Animals
Anoxia / blood,  etiology,  physiopathology*
Dogs
Hemodynamics / drug effects
Meclofenamic Acid / pharmacology
Prostaglandins / metabolism*
Pulmonary Atelectasis / complications*
Thromboxane B2 / blood
Vasoconstriction*
Chemical
Reg. No./Substance:
0/Prostaglandins; 54397-85-2/Thromboxane B2; 58962-34-8/6-Ketoprostaglandin F1 alpha; 644-62-2/Meclofenamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regulation of increase in anastomotic blood flow following pulmonary arterial occlusion.
Next Document:  Macrophage activation by PAF incorporated into dipalmitoylphosphatidylcholine-cholesterol liposomes.